Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
portion decrease » proportional decrease (Expand Search)
point decrease » point increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
portion decrease » proportional decrease (Expand Search)
point decrease » point increase (Expand Search)
-
61
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
62
-
63
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
64
-
65
-
66
-
67
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
68
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
69
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
70
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
71
-
72
-
73
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
74
-
75
-
76
-
77
-
78
The Samn-Perelli Scale is a 7-point Likert scale used to assess fatigue [42, 45].
Published 2024Subjects: -
79
Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).
Published 2025“…<p>Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).…”
-
80
Supplementary Material for: Decreased Lactococcus lactis and propionic acid in feces of patients with Moyamoya disease: Possible implications of immune dysregulation
Published 2025“…Results: There were no significant differences in α- and b-diversities among feces from the MMD patients and controls. …”